home / stock / eypt / eypt quote
Last: | $8.01 |
---|---|
Change Percent: | 0.0% |
Open: | $8.31 |
Close: | $8.01 |
High: | $8.43 |
Low: | $7.73 |
Volume: | 820,289 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.01 | $8.31 | $8.01 | $8.43 | $7.73 | 820,289 | 07-02-2024 |
$8.31 | $8.68 | $8.31 | $8.82 | $8.02 | 685,851 | 07-01-2024 |
$8.7 | $8.72 | $8.7 | $9.24 | $8.56 | 2,636,508 | 06-28-2024 |
$8.75 | $8.22 | $8.75 | $8.75 | $8.1 | 711,392 | 06-27-2024 |
$8.19 | $8.48 | $8.19 | $8.62 | $8.14 | 644,706 | 06-26-2024 |
$8.26 | $8.5 | $8.26 | $8.71 | $8.19 | 942,385 | 06-25-2024 |
$8.52 | $8.44 | $8.52 | $8.78 | $8.36 | 629,387 | 06-24-2024 |
$8.47 | $8.2 | $8.47 | $8.55 | $7.95 | 1,114,488 | 06-21-2024 |
$8.16 | $8.66 | $8.16 | $8.9899 | $8.11 | 932,611 | 06-20-2024 |
$8.69 | $9.03 | $8.69 | $9.1 | $8.655 | 552,117 | 06-19-2024 |
$8.69 | $9.03 | $8.69 | $9.1 | $8.655 | 552,117 | 06-18-2024 |
$9.01 | $9.4 | $9.01 | $9.4 | $8.98 | 546,143 | 06-17-2024 |
$9.38 | $9.22 | $9.38 | $9.5 | $9.11 | 521,861 | 06-14-2024 |
$9.29 | $9.36 | $9.29 | $9.49 | $9.06 | 767,760 | 06-13-2024 |
$9.32 | $9.52 | $9.32 | $9.87 | $9.29 | 676,660 | 06-12-2024 |
$9.42 | $9.04 | $9.42 | $9.46 | $8.76 | 573,441 | 06-11-2024 |
$9.08 | $8.95 | $9.08 | $9.18 | $8.78 | 1,136,054 | 06-10-2024 |
$9.1 | $9.16 | $9.1 | $9.31 | $8.88 | 727,089 | 06-07-2024 |
$9.27 | $9.72 | $9.27 | $9.85 | $9.22 | 802,644 | 06-06-2024 |
$9.79 | $9.18 | $9.79 | $9.8 | $8.9401 | 1,375,977 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
EyePoint Pharmaceuticals Inc. Company Name:
EYPT Stock Symbol:
NASDAQ Market:
EyePoint Pharmaceuticals Inc. Website:
– Phase 3 trial design for the LUGANO and LUCIA pivotal non-inferiority trials of DURAVYU in wet AMD based on positive EOP2 meeting with FDA; on track for trial initiation in 2H 2024 – – Positive twelve-month safety and efficacy data from Phase 2 DAVIO 2 clinical tria...
WATERTOWN, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company will host an R...
2024-06-11 11:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...